Key Studies in Genitourinary, Gastrointestinal, Breast, and Lung Cancers: CCO Independent Conference Highlights of the 2021 Virtual ESMO Annual Meeting

• CME

At the 2021 virtual ESMO annual meeting, new clinical trial data on genitourinary, gastrointestinal, breast, and lung cancer were reported. In this module, Eva M. Ciruelos, MD, PhD; Karim Fizazi, MD, PhD; Eric Van Cutsem, MD, PhD; and Vamsidhar Velcheti, MD, review and discuss the clinical implications of key studies in these malignancies that were presented at the meeting.

Please note that the slide thumbnails in this activity link to brief PowerPoint slidesets, each focused on the specific study or topic of interest. These slidesets may be downloaded by clicking on any of the thumbnails within the activity.

Clinical Care Options plans to measure the educational impact of this activity. Several questions will be asked twice: once at the beginning of the activity and then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.